Mechanics of a heartbeat are controlled by molecular strut in heart muscle cellsApril 21, 2016
PHILADELPHIA - On top of the meaning and mystery that humans heap on the heart, it is first and foremost, a muscle. And one that beats about once a second for a person's entire life, with no rest. Given its vital importance, it's ironic researchers have only recently made direct observations of its subcellular parts in motion.
Now, using new high-resolution microscopy, a team from the Perelman School of Medicine and the School of Engineering and Applied Science at the University of Pennsylvania found that molecular struts called microtubules (MT) interact with the heart's contractile machinery to provide mechanical resistance for the beating of the heart. Their findings, which could have implications for better understanding how microtubules affect the mechanics of the beating heart, and what happens when this goes awry, are published this week in Science.
Microtubules of the cell's inner support system have diverse structural and signaling roles in heart muscle cells. Alterations in this microtubule network have been suggested to contribute to heart disease, but just how microtubules behave in the beating heart is poorly understood.
Direct observation of MTs during contraction is the most straightforward way to shed light on their contributions to heart function. The team observed temporal and spatial changes in MT shape during heart contraction. In addition, recent studies suggest that chemical changes to the MTs, called detyrosination (the removal of a tyrosine chemical group), regulate mechanotransduction, but it was unclear how.
"We asked whether detyrosination alters how microtubules respond to changing physical pressure each time the heart contracts and relaxes," said senior author Ben Prosser, PhD, an assistant professor of Physiology. "To answer these questions we used advanced imaging techniques to explore microtubule behavior in beating heart muscle cells from rodents."
Under the microscope, cardiac muscle looks like interconnected bundles, termed myocytes. Heart myocytes are narrower and much shorter than skeletal muscle cells, with many mitochondria that produce the energy needed for all of that beating over a lifetime. "Heart muscle tissue is highly organized and that's why it's such an efficient machine," Prosser explained.
During contraction the somewhat stiff MTs must somehow accommodate to the changing shape of myocytes. In this new study, the researchers found that in a typical myocyte this shape shift is accomplished by the MT deforming into a buckled spring that returns to an identical resting configuration after each beat. MTs are directly connected to the contractile machinery called sarcomeres. This link is at least partly accomplished via a protein called desmin that anchors MTs to the sarcomere, giving it a lattice-like structure.
The physical link between MTs and the sarcomere is highly dependent on detyrosination, so they tweaked the MT-sarcomere system to locate its weakest link. The team found that in myocytes in which detyrosination was suppressed MTs often accommodated contraction by sliding past each other rather than buckling as the sarcomere shortened. Disrupting the MT-sarcomere interaction allowed the sarcomere, and thus the heart cell, to shorten farther and faster, as well as decreased the cell's overall stiffness.
"We speculate that there should be some optimum set point to the system and pushing it too far in either direction could be detrimental," Prosser said. "The heart is a carefully honed machine that often operates within a narrow regime and pushing it outside this regime is often what leads to dysfunction over time."
Conversely, they found that increasing detyrosination increased myocyte stiffness and impeded contraction. "This was a seeing-is-believing moment," Prosser said. "We can now really observe how too many stiff microtubule struts would be detrimental to the heart over time. Our bioengineering coauthors precisely measured the microtubule contribution to cellular mechanics and quantified mathematically how this affected heart cell performance."
"We developed a mathematical microstructural model to analyze how active contractile forces lead to buckling of microtubules and to quantitatively interpret the measurements from Prosser lab and validate their hypothesis," said Vivek Shenoy, PhD, a professor of Materials Science and Engineering.
The team's findings are consistent with clinical data that shows a direct correlation between excess detyrosination and a decline in heart function in patients with hypertrophic cardiomyopathy (thickened heart muscle). The team found that detyrosination was greater in diseased hearts, by comparing human heart tissue donated from heart transplant patients with normal heart tissue from brain-dead donors, obtained from transplant cardiologist and coauthor Ken Margulies, MD, a professor of Medicine.
Cells from diseased hearts had more MTs, and these MTs showed more detyrosination. This process correlated with impaired function within this patient population in that their whole hearts, before the transplant, had a lower ejection fraction that correlated with greater detyrosination.
"Essentially we found that excess detyrosination promotes the interaction between microtubules and the sarcomere, increasing resistance to contraction and so may contribute to reductions in cardiac function in certain disease states." Prosser said. "If we can break the microtubule crosslink, then the sarcomere can shorten more easily without the stiff, connected microtubules. We want the microtubules to slide back and forth more smoothly, which lets the sarcomere and therefore the heart to contract more, allowing the heart to pump blood more efficiently. This is useful to counteract the higher blood pressures outside the heart seen in many patients. Overall we want to increase the heart's contractility and beating strength."
The team is now asking whether specific drugs that reduce detyrosination can make diseased heart muscle beat stronger. They have tested this in mice and it works as predicted. Their next step is moving on to human diseased heart cells.
This work was supported by funding from the National Institutes of Health NIAMS (T32AR053461-09), NHLBI (T32HL007954, R00-HL114879, HL089847 HL105993), the National Science Foundation (DMR08-32802, DMR09-07493, CMMI-1312392), and the National Institute of Biomedical Imaging and Bioengineering (R01EB017753).
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $5.3 billion enterprise.
The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 18 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $373 million awarded in the 2015 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center -- which are recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report -- Chester County Hospital; Lancaster General Health; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2015, Penn Medicine provided $253.3 million to benefit our community.
University of Pennsylvania School of Medicine
Related Heart Disease Articles:
People living in parts of Ontario with better access to preventive health care had lower rates of cardiac events compared to residents of regions with less access, found a new study published in CMAJ (Canadian Medical Association Journal).
Improving physical function among older adults with heart disease helps heart health and even the oldest have a better quality of life and greater independence.
Nearly half of all deaths due to heart disease, stroke, and type 2 diabetes in the US in 2012 were associated with suboptimal consumption of certain dietary factors, according to a study appearing in the March 7 issue of JAMA.
For the first time, researchers have pinpointed a type of heart fat, linked it to a risk factor for heart disease and shown that menopausal status and estrogen levels are critical modifying factors of its associated risk in women.
Pregnant women with congenital heart defects or type 2 diabetes have a higher risk of giving birth to babies with severe congenital heart disease and should be monitored closely in the prenatal period, according to a study published in CMAJ.
A novel heart valve replacement method is revealed today that offers hope for the thousands of patients with rheumatic heart disease who need the procedure each year.
For patients age 50 and younger, the risk of premature death after a heart attack has dropped significantly, but their risk is still almost twice as high when compared to the general population, largely due to heart disease and other smoking-related diseases The risk of heart attack can be greatly reduced by quitting smoking, exercising and following a healthy diet.
Oranges and other citrus fruits are good for you -- they contain plenty of vitamins and substances, such as antioxidants, that can help keep you healthy.
A history of gallstone disease was linked to a 23 percent increased risk of developing coronary heart disease.
Coronary heart disease is one of the leading causes of death in the United States.
Related Heart Disease Reading:
Prevent and Reverse Heart Disease: The Revolutionary, Scientifically Proven, Nutrition-Based Cure
by Caldwell B. Esselstyn Jr. (Author)
The New York Times bestselling guide to the lifesaving diet that can both prevent and help reverse the effects of heart disease
Based on the groundbreaking results of his twenty-year nutritional study, Prevent and Reverse Heart Disease by Dr. Caldwell Esselstyn illustrates that a plant-based, oil-free diet can not only prevent the progression of heart disease but can also reverse its effects. Dr. Esselstyn is an internationally known surgeon, researcher and former clinician at the Cleveland Clinic and a featured expert in the acclaimed documentary Forks... View Details
Pathophysiology of Heart Disease: A Collaborative Project of Medical Students and Faculty
by Leonard S. Lilly MD (Author)
Publisher’s Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product.
Specifically designed to prepare medical students for their initial encounters with patients with heart disease, this award-winning text bridges basic cardiac physiology with clinical care. Written by internationally recognized Harvard Medical School faculty and select medical students, Pathophysiology of Heart Disease, Sixth Edition provides a solid foundation of knowledge... View Details
The End of Heart Disease: The Eat to Live Plan to Prevent and Reverse Heart Disease
by Dr. Joel Fuhrman (Author)
The New York Times bestselling author of Eat to Live, Super Immunity, The End of Diabetes, and The End of Dieting presents a scientifically proven, practical program to prevent and reverse heart disease, the leading cause of death in America—coinciding with the author’s new medical study revealing headline-making findings.
Dr. Joel Fuhrman, one of the country’s leading experts on preventative medicine, offers his science-backed nutritional plan that addresses the leading cause of death in America: heart disease. An expert in the science of food, Dr.... View Details
Dr. Dean Ornish's Program for Reversing Heart Disease: The Only System Scientifically Proven to Reverse Heart Disease Without Drugs or Surgery
by Dean Ornish (Author)
Dr. Dean Ornish's Program for Reversing Heart Disease: The Only System Scientifically Proven to Reverse Heart Disease Without Drugs or Surgery View Details
The Simple Heart Cure: The 90-Day Program to Stop and Reverse Heart Disease
by Chauncey Crandall (Author)
Heart disease kills more people than any other medical condition. And no one is more aware of this than top cardiologist Dr. Chauncey Crandall, who has performed over 40,000 heart procedures during his career.
In his new book, The Simple Heart Cure, you’ll find this top doc’s groundbreaking approach to preventing and reversing heart disease an approach honed by his study of foreign cultures free of heart disease and decades of experience helping patients achieve a healthier heart at any age.
Dr. Crandall is living proof of his program’s success. At the age of... View Details
What Your Doctor May Not Tell You about Heart Disease
by Mark Houston (Author)
Coronary heart disease has long been the number one killer in this country, and for decades, we have been told about five basic risk factors: elevated cholesterol, high blood pressure, diabetes, obesity, and smoking. But the truth is that heart disease is much more complex-- with close to 400 risk factors!
In this innovative guide, Dr. Mark Houston helps readers discover the causes of heart disease, how to prevent and treat its debilitating effects via nutrition, nutritional supplements, exercise, weight management, and lays to rest to various myths (cholesterol is not the... View Details
The Prevent and Reverse Heart Disease Cookbook: Over 125 Delicious, Life-Changing, Plant-Based Recipes
by Ann Crile Esselstyn (Author), Jane Esselstyn (Author)
The long-awaited cookbook companion to the revolutionary New York Times bestseller Prevent and Reverse Heart Disease.
“I hope you'll treat yourself to one of these recipes and just open that door. I guarantee you won't close it!"
—Samuel L. Jackson
Hundreds of thousands of readers have been inspired to turn their lives around by Dr. Caldwell B. Esselstyn’s Jr.’s bestseller, Prevent and Reverse Heart Disease. The plant-based nutrition plan Dr. Esselstyn advocates based on his twenty-year nutritional study—the most... View Details
The 30-Day Heart Tune-Up: A Breakthrough Medical Plan to Prevent and Reverse Heart Disease
by Steven Masley (Author), Douglas D. Schocken (Foreword)
THE 30-DAY HEART TUNE-UP takes readers step by step through a revolutionary program to tune up their hearts, energy, waistlines, and sex lives, with 60 delicious recipes to help jump-start a heart-healthy diet. Cardiovascular disease is the #1 killer of Americans today. But, the good news is that everyone-regardless of size, genetics, gender, or age-can treat arterial plaque and prevent heart attacks and strokes with this book. The keys to the program are shrinking arterial plaque, improving circulation, and strengthening your heartbeat. The tools in this book include... View Details
A Woman's Guide to Living with Heart Disease
by Carolyn Thomas (Author), Martha Gulati (Foreword)
Heart disease is the leading cause of death for women worldwide. Yet most people are still unaware that heart disease is not just a man’s problem. Carolyn Thomas, a heart attack survivor herself, is on a mission to educate women about their heart health. Based on her popular Heart Sisters blog, which has attracted more than 10 million views from readers in 190 countries, A Woman's Guide to Living with Heart Disease combines personal experience and medical knowledge to help women learn how to understand and manage a catastrophic diagnosis.
In A Woman's Guide to... View Details
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 11e
by Douglas P. Zipes MD (Author), Peter Libby MD PhD (Author), Robert O. Bonow MD MS (Author), Douglas L. Mann MD (Author), Gordon F. Tomaselli MD (Author)
Trusted by generations of cardiologists for the latest, most reliable guidance in the field, Braunwald’s Heart Disease, 11th Edition, remains your #1 source of information on rapidly changing clinical science, clinical and translational research, and evidence-based medicine. This award-winning text has been completely updated, providing a superior multimedia reference for every aspect of this fast-changing field, including new material about almost every topic in cardiology.A unique update program by Dr. Braunwald creates a "living textbook" by featuring... View Details